Navigation Links
HealthPartners Among Best Health Plans in the Nation for 3rd Year in U.S. News/NCQA 'America's Best Health Plans' 2007
Date:10/30/2007

BLOOMINGTON, Minn., Oct. 30 /PRNewswire-USNewswire/ -- HealthPartners is among the top 50 best commercial and Medicare health plans in the nation according to the 2007 U.S. News & World Report/NCQA America's Best Health Plans issue. HealthPartners is featured in the print edition of the Nov. 5, 2007 magazine which compares the quality of care and customer satisfaction among 700 commercial, Medicare and Medicaid plans from across the nation.

HealthPartners scored in the top 25 percent nationally in the following areas:

Clinical measures

-- Cancer screening for breast, colorectal and cervical cancer

-- Heart disease treatment: beta blocker treatment, blood pressure

control and cholesterol management

-- Diabetes care: eye exams, cholesterol control. blood sugar

testing and control

-- Immunizations for children

-- Depression medication management

-- Low back pain: appropriate diagnostic imaging

Member satisfaction

-- Getting access to care

-- Overall experience with the health plan

-- Rating of the health plan's doctors

HealthPartners commercial plan is the 38th highest-ranked plan nationally and its Medicare plan is the 33rd highest-ranked plan. HealthPartners commercial and Medicare plans were also ranked in the top 50 health plans in the 2006 and 2005 reports.

"This affirms that our work to offer the best possible health care and support the best possible health for our members is achieving results. We make that effort our top priority and care deeply about improving healthcare and the value we offer our members." said Mary Brainerd, HealthPartners president and CEO.

NCQA, the National Committee for Quality Assurance, is a nonprofit organization that accredits and certifies health care organizations and tracks and measures health plan performance. The 2007 America's Best Health Plans report is available at '/>"/>

SOURCE HealthPartners
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Alternative medicine more popular among HIV positive patients
2. Easing Fears Among Asthmatics
3. Tool To Detect Health Literacy among Patients
4. Higher Rates Of Diabetes Found Among The Poor
5. Rise In Obesity Among North Qeenslanders
6. Reach Of The Morning-After Pill Treatment Inadequate Among Sexual Assault Victims
7. Poor diet among smokers
8. Breast screening among diabetic women
9. Losing that baby fat among women
10. Poor diet among smokers
11. Physical activity less among black girls
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... FL (PRWEB) May 23, 2013 ... regenerative medicine company focused on the commercialization of ... and regeneration, today announced that the Company and ... million grant, for which AxoGen’s portion is approximately ... administrated by the U.S. Department of Defense (DoD) ...
(Date:5/23/2013)... 2013 Hile Design LLC is pleased ... awarded a Silver Creative Award at the Summit International ... entry was for its “Open Doors” animation promoting Scio ... in the 2013 District 6 ADDY Awards for the ... Creative Award recognizes and celebrates the creative achievements of ...
(Date:5/23/2013)... Utah (PRWEB) May 23, 2013 Registered ... R.D., published an article today on Tatalou.com offering helpful ... vacation. , The article, titled “ How to Stay ... important to carry hand sanitizer, when it’s safe to ... out for seafood, the importance of staying hydrated and ...
(Date:5/23/2013)... OH and Durham, NC (PRWEB) May 23, 2013 ... and commercialization firm that funds and develops innovative ... Deep Brain Innovations, LLC (DBI). DBI will ... optimize deep brain stimulation (DBS) therapy for patients ... is effective in treating Parkinson’s disease and generates ...
(Date:5/23/2013)... Consortium, Ltd., issued the following statement today on ... Reform of chemical safety legislation will succeed only ... Ensuring the safety and appropriate use of chemicals ... Toxic Substances Control Act is a critical opportunity ... transforming toxicity testing "from a system based on ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 2Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 3Health News:How to Stay Healthy While Traveling 2Health News:NDI Launches Deep Brain Innovations, LLC 2Health News:NDI Launches Deep Brain Innovations, LLC 3
... global research,organization, announced that it has appointed new staff ... Resourcing Solutions,division. Maria Sanchez Garcia will lead the group ... whilst Hannah King joins our United,Kingdom team to focus ... very pleased to help in the continued growth of ...
... deal demonstrates commitment to dermatology and innovation, ... Stiefel Laboratories, Inc.,the world,s largest independent pharmaceutical ... has completed its previously announced,acquisition of Princeton, ... of the acquisition, all remaining outstanding shares ...
... Call and Webcast Scheduled for August 7, 2008 ... Aug. 6 The Ensign,Group, Inc. (Nasdaq: ... group of,skilled nursing, rehabilitative care services and assisted ... quarter of fiscal,year 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ...
... ... Diluted FAD ... Second Quarter Investments $250 Million, NEWPORT BEACH, Calif., ... operations,and investment activity for the second quarter and the six months ended,June 30, 2008., ...
... put themselves at increased risk for second malignancies , , ... British adults who survived childhood cancers currently smoke, while ... in their lives, a new study reports. , ... cancer have a greater chance of developing cardiovascular disease, ...
... Aug. 6 AMN Healthcare Services,Inc. (NYSE: AHS ... leader in all of its business segments today reported ... quarter last year and a 7%,increase from last quarter. ... Nurse & Allied, Locum Tenens and,Physician Permanent Placement, experienced ...
Cached Medicine News:Health News:Chiltern's Resourcing Solutions Division Appoints New Managers to Spain and the United Kingdom 2Health News:Stiefel Laboratories Completes Acquisition of Barrier Therapeutics 2Health News:Stiefel Laboratories Completes Acquisition of Barrier Therapeutics 3Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 2Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 3Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 4Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 5Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 6Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 7Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 8Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 9Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 10Health News:The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance 11Health News:NHP Reports Second Quarter 2008 Earnings 2Health News:NHP Reports Second Quarter 2008 Earnings 3Health News:NHP Reports Second Quarter 2008 Earnings 4Health News:NHP Reports Second Quarter 2008 Earnings 5Health News:NHP Reports Second Quarter 2008 Earnings 6Health News:NHP Reports Second Quarter 2008 Earnings 7Health News:NHP Reports Second Quarter 2008 Earnings 8Health News:NHP Reports Second Quarter 2008 Earnings 9Health News:NHP Reports Second Quarter 2008 Earnings 10Health News:NHP Reports Second Quarter 2008 Earnings 11Health News:NHP Reports Second Quarter 2008 Earnings 12Health News:NHP Reports Second Quarter 2008 Earnings 13Health News:NHP Reports Second Quarter 2008 Earnings 14Health News:One-Fifth of British Childhood Cancer Survivors Smoke 2Health News:AMN Healthcare Reports Second Quarter 2008 Results 2Health News:AMN Healthcare Reports Second Quarter 2008 Results 3Health News:AMN Healthcare Reports Second Quarter 2008 Results 4Health News:AMN Healthcare Reports Second Quarter 2008 Results 5Health News:AMN Healthcare Reports Second Quarter 2008 Results 6Health News:AMN Healthcare Reports Second Quarter 2008 Results 7Health News:AMN Healthcare Reports Second Quarter 2008 Results 8Health News:AMN Healthcare Reports Second Quarter 2008 Results 9
(Date:5/22/2013)... PLAINS, N.Y. , May 22, 2013  The ... million to Valor Biotherapeutics, LLC, a joint ... of pre-clinical development, manufacturing, and a Phase I clinical ... the poor outcomes faced by many patients with indolent ... rituximab. Valor,s protein, IGN002, is a ...
(Date:5/22/2013)... CAESAREA, Israel , May 22, 2013 ... presented from the DEFLECT-I study demonstrates that Keystone Heart,s ... volume during TAVR (Transcatheter Aortic Valve Replacement) procedures when ... Advisory Board announces consensus on the importance of preserving ... and need for cerebral protection during cardiovascular procedures to ...
(Date:5/22/2013)... -- For the 3% of the population that suffer from ... anxiety-inducing and disabling.  While more than half of these ... hyperhidrosis is a serious medical condition.  Finally, there is ... Dr. Bruce Katz , ... New York , is leading an ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4Is There Finally A Way To Stop Severe Excessive Sweating? 2
... YORK, May 12, 2011 Reportlinker.com announces ... available in its catalogue: ... 2017 http://www.reportlinker.com/p0493115/Asia-Pacific-Hospital-Supplies-Market-Outlook-to-2017.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... Outlook to 2017 Summary ...
... Korea, May 11, 2011 CrystalGenomics, Inc., a biopharmaceutical ... that the draft Clinical Study Report (CSR) from CG400549,s ... been received. CG400549 is a potential first-in-class ... a critical enzyme in generating bacterial membrane and has ...
Cached Medicine Technology:Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 2Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 3Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 4Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 5Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 6Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 7Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 8Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 9Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 10Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 11Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 12Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 13Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 14Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 15CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: